<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE resolution PUBLIC "-//US Congress//DTDs/res.dtd//EN" "res.dtd">
<resolution dms-id="H76E906921695492F9D6910559C9BFF14" key="H" public-private="public" resolution-stage="Introduced-in-House" resolution-type="house-resolution" star-print="no-star-print">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HRES 109 IH: Expressing support for the designation of February 28, 2015, as “Rare Disease Day”.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-02-12</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">IV</distribution-code>
		<congress display="yes">114th CONGRESS</congress>
		<session display="yes">1st Session</session>
		<legis-num>H. RES. 109</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action display="yes">
			<action-date date="20150212">February 12, 2015</action-date>
			<action-desc><sponsor name-id="C001072">Mr. Carson of Indiana</sponsor> (for himself and <cosponsor name-id="M001150">Mrs. Miller of Michigan</cosponsor>) submitted the following resolution; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc>
		</action>
		<legis-type>RESOLUTION</legis-type>
		<official-title display="yes">Expressing support for the designation of February 28, 2015, as <quote>Rare Disease Day</quote>.</official-title>
	</form>
	<preamble>
 <whereas><text>Whereas rare diseases and disorders are those which affect small patient populations, typically populations smaller than 200,000 individuals in the United States;</text>
 </whereas><whereas><text>Whereas nearly 7,000 rare diseases affect nearly 30,000,000 people in the United States and their families;</text>
 </whereas><whereas><text>Whereas over half of all rare diseases affect children;</text> </whereas><whereas><text>Whereas many rare diseases are serious, life-threatening, and lack an effective treatment;</text>
 </whereas><whereas><text>Whereas rare diseases and conditions cross the medical spectrum and include a broad range of diseases such as epidermolysis bullosa, progeria, sickle cell anemia, Tay-Sachs, Leigh’s disease, WAGR Syndrome, cystic fibrosis, most childhood cancers, and fibrodysplasia ossificans progressiva;</text>
 </whereas><whereas><text>Whereas people with rare diseases experience challenges that include difficulty in obtaining an accurate diagnosis, limited treatment options, and difficulty finding physicians or treatment centers with expertise in their disease;</text>
 </whereas><whereas><text>Whereas more than 450 drugs and biologies have been approved for the treatment of rare diseases according to the Food and Drug Administration, millions of people in the United States have rare diseases for which there is no approved treatment;</text>
 </whereas><whereas><text>Whereas challenges to reimbursement for life-altering and often life-saving treatments still exist, such as in reimbursement for medical foods that treat rare metabolic disorders;</text>
 </whereas><whereas><text>Whereas great strides have been made in research and treatment for rare diseases as a result of the Orphan Drug Act and amendments made by that Act;</text>
 </whereas><whereas><text>Whereas the Food and Drug Administration has taken great strides in involving the patient in the drug review process as part of its Patient-Focused Drug Development program, an initiative that originated in the Food and Drug Administration Safety and Innovation Act;</text>
 </whereas><whereas><text>Whereas both the Food and Drug Administration and the National Institutes of Health have established special offices to advocate for rare disease research and treatments;</text>
 </whereas><whereas><text>Whereas the National Organization for Rare Disorders, an organization established in 1983 to provide services to, and advocate on behalf of, patients with rare diseases, was a primary force behind the enactment of the Orphan Drug Act and remains a critical public voice for people with rare diseases;</text>
 </whereas><whereas><text>Whereas 2015 marks the 32nd anniversary of the Orphan Drug Act and the National Organization for Rare Disorders;</text>
 </whereas><whereas><text>Whereas the National Organization for Rare Disorders sponsors <quote>Rare Disease Day</quote> in the United States to increase public awareness of rare diseases;</text> </whereas><whereas><text>Whereas <quote>Rare Disease Day</quote> is a global event occurring annually on the last day of February;</text>
 </whereas><whereas><text>Whereas <quote>Rare Disease Day</quote> was observed in the United States for the first time on February 28, 2009; and</text> </whereas><whereas><text>Whereas <quote>Rare Disease Day</quote> is anticipated to continue to be observed globally in years to come, providing hope and information for rare disease patients around the world: Now, therefore, be it</text></whereas></preamble>
	<resolution-body id="H8EB093C9DB654A9D867C7E72B34DCB61" style="traditional">
 <section display-inline="yes-display-inline" id="H5B3DC33A239D4FA3BB13C62D5AD61A09" section-type="undesignated-section"><enum></enum><text>That the House of Representatives—</text> <paragraph id="H2191BFE33BE048D2B22592C87F6509F5"><enum>(1)</enum><text display-inline="yes-display-inline">supports the designation of <quote>Rare Disease Day</quote>;</text>
 </paragraph><paragraph id="H7F5BF5BCB7FE431F9E11491C132A2C92"><enum>(2)</enum><text>recognizes the importance of improving awareness and encouraging accurate and early diagnosis of rare diseases and disorders; and</text>
 </paragraph><paragraph id="HC6328A37AABC423DB2731C080B1FBA62"><enum>(3)</enum><text>supports a national and global commitment to improving access to, and developing new treatments, diagnostics, and cures for, rare diseases and disorders.</text>
			</paragraph></section></resolution-body>
</resolution>


